Blue Trust Inc’s Mural Oncology MURA Stock Holding History

Blue Trust Inc’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6	Closed	-$19	–	2780
2024 Q3	$19	Hold	6	–	–	﹤0.01%	2891
2024 Q2	$29	Buy	+6	New	+$22	﹤0.01%	2690

Other funds holding MURA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Blue Trust Inc's MURA Position: Q4 2024 in Review

Blue Trust Inc sold out of Mural Oncology (MURA) in Q4 2024, closing a stake of 6 shares — an estimated $19 sold.

Blue Trust Inc first reported a position in MURA in Q2 2024 and held it in 2 quarters. The position peaked at $29 in Q2 2024. 76 funds tracked by Wall St. Rank hold MURA as of Q4 2024.

Blue Trust Inc reported no remaining Mural Oncology position as of Q4 2024 after selling out during the quarter.
Blue Trust Inc sold 6 Mural Oncology shares in Q4 2024, an estimated $19.
Blue Trust Inc first reported a position in Mural Oncology in Q2 2024 and held it in 2 quarters.
Blue Trust Inc's Mural Oncology position peaked at $29 in Q2 2024.
76 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.